06
June 2023
Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting
The data released at ASCO includes a larger population of patients for efficacy analysis and a longer follow-up period, compared with results of AACR poster.